Related Experiment Video
Updated: Aug 5, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
The Hood Technique for Robot-Assisted Radical Cystoprostatectomy with Intracorporeal Neobladder
Ahmed Eraky1, Reza Mehrazin1, Neeraja Tillu1
1Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Journal of Endourology
|August 4, 2026
Summary
The modified Hood technique for robot-assisted radical cystoprostatectomy (RARC) with neobladder reconstruction shows promising early continence recovery. This approach preserves critical structures, leading to good functional and oncologic outcomes in male patients.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- The Hood technique, initially for prostatectomy, preserves continence-related structures.
- Radical cystoprostatectomy (RARC) involves extensive dissection, requiring adaptation of the Hood technique.
- Intracorporeal neobladder reconstruction is a complex procedure following RARC.
Purpose of the Study:
- To adapt and describe the Hood technique for RARC with intracorporeal neobladder reconstruction.
- To report early feasibility, functional outcomes (continence), and oncologic outcomes.
- To evaluate the potential of this modified approach for preserving urinary continence.
Main Methods:
- Retrospective review of 40 male patients undergoing RARC with intracorporeal neobladder using the Hood technique (2019-2023).
- Continence defined as 0-1 pad/day; assessed via pad count at standardized intervals.
- Kaplan-Meier analysis for time to continence; perioperative and oncologic outcomes analyzed descriptively.
Main Results:
- Median operative time: 335 minutes; estimated blood loss: 400 mL; hospital stay: 4 days.
- Daytime continence reached 92% by 6 months; nighttime continence reached 62% by ≥12 months.
- Negative surgical margins for urothelial carcinoma; major complications occurred in 7.5-10% of patients.
Conclusions:
- The adapted Hood technique is feasible for RARC with intracorporeal neobladder.
- Encouraging early continence recovery was observed without short-term adverse oncologic outcomes.
- Further comparative studies are warranted to validate these findings.